BioSpace News Archive

Entasis Therapeutics Holdings Inc. today announced its first quarter 2022 financial results and provided a business update.

VERO Biotech Inc today announced that the company was awarded the prestigious Golden Helix “Innovation Award” for its breakthrough development of the GENOSYL® Delivery System

Solid Biosciences Inc. today announced an update to its strategic priorities to focus on developing SGT-001 and SGT-003. The company also announced financial results for the first quarter ended March 31, 2022.

Amarantus Bioscience Holdings, Inc. today released a letter to its shareholders announcing it has entered into a non-binding term sheet to sell the Company’s Engineered Skin Substitute (ESS).

Surmodics, Inc. today announced results for its fiscal 2022 second quarter ended March 31, 2022 and updated its financial outlook for its fiscal 2022.

Stevanato Group S.p.A. today announced that it will issue financial results for the first quarter of 2022 on Tuesday, May 10, 2022, at 6:30 a.m. Eastern Time (12:30 Central European Time).

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the BofA Securities 2022 Healthcare Conference on May 11, 2022 at the Encore Hotel in Las Vegas, Nevada.

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its first quarter financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 11, 2022.

Erasca, Inc. announced the appointment of Jean Liu to its board of directors and to its audit committee.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.